1. Home
  2. ADPT vs POR Comparison

ADPT vs POR Comparison

Compare ADPT & POR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$27.73

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Portland General Electric Co

POR

Portland General Electric Co

N/A

Current Price

$45.29

Market Cap

5.5B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
ADPT
POR
Founded
2009
1889
Country
United States
United States
Employees
N/A
2915
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.5B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
ADPT
POR
Price
$27.73
$45.29
Analyst Decision
Strong Buy
Hold
Analyst Count
8
12
Target Price
$33.86
★ $50.90
AVG Volume (30 Days)
★ 2.1M
1.9M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
★ 4.86%
EPS Growth
★ 63.89
N/A
EPS
N/A
★ 1.98
Revenue
$276,976,000.00
★ $3,576,000,000.00
Revenue This Year
$10.85
$2.75
Revenue Next Year
$21.60
$7.41
P/E Ratio
★ N/A
$22.92
Revenue Growth
★ 54.77
3.95
52 Week Low
$12.00
$43.26
52 Week High
$32.21
$54.62

Technical Indicators

Market Signals
Indicator
ADPT
POR
Relative Strength Index (RSI) 49.06 48.18
Support Level $24.02 $43.29
Resistance Level $29.92 $45.72
Average True Range (ATR) 1.71 0.77
MACD -0.09 0.01
Stochastic Oscillator 31.91 24.49

Price Performance

Historical Comparison
ADPT
POR

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About POR Portland General Electric Co

Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two-thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.6 gigawatts of gas, coal, wind, and hydro generation, along with 300 megawatts of energy storage. In February 2026, PGE proposed acquiring utilities in Washington state from Berkshire Hathaway Energy.

Share on Social Networks: